Levocet Tablet contains Levocetirizine 5 mg, an advanced second-generation antihistamine indicated for the relief of symptoms associated with allergic conditions such as allergic rhinitis, chronic idiopathic urticaria, and other histamine-mediated allergic disorders. Levocetirizine is the active enantiomer of cetirizine and exhibits selective peripheral H1-receptor antagonism, effectively reducing the effects of histamine without significant sedation or anticholinergic side effects commonly seen with first-generation antihistamines. The tablet formulation ensures convenient oral administration with rapid absorption and onset of action, typically within one hour, providing sustained symptom control over 24 hours. Levocetirizine is well-tolerated, with a favorable safety profile demonstrated in clinical studies, making it suitable for both adult and pediatric patients aged six years and above. It is metabolized minimally by the liver and primarily excreted unchanged via the kidneys, necessitating dose adjustments in patients with renal impairment. Levocet Tablet should be used under medical supervision, especially in individuals with pre-existing renal conditions or those taking concomitant medications that may affect renal function. Common adverse effects may include mild somnolence, dry mouth, and headache. Levocetirizine offers effective, long-lasting relief from allergic symptoms, improving patient quality of life.